AURA
AURA
NASDAQ · Biotechnology

Aura Biosciences Inc

$6.35
+0.01 (+0.16%)
As of Nov 7, 2:09 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +411.2% upside
Low Target $26.53
Average Target $32.46
High Target $55.40
Current Price $6.35
Current
$6.35
Target
$32.46
$26.53 $32.46 avg $55.40
Scenario Analysis
Bear Case
$26.53
317.8%
Low target
Base Case
$32.46
+411.2%
Avg target
Bull Case
$55.40
+772.4%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$9.54
-33.4% from high
52-Week Low
$4.73
+34.2% from low
Target vs 52W High
$32.46
+240.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%